KRASG12D亚型和并发性致病突变对高级非小细胞肺癌结果的影响
Enrique Caballé-Perez1,2, Norma Hernández-Pedro2, Maritza Ramos-Ramírez1
1Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
概括
这项研究揭示了肺腺癌中KRAS-G12D突变与拉丁美洲患者更好的治疗反应和生存有关. 了解这些KRAS亚型对于个性化肺癌治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 基尔斯顿大鼠肉瘤病毒 (KRAS) 瘤基因突变是肺腺癌的关键驱动因素,影响10-40%的患者.
- 肺腺癌的临床结果是高度可变的,受同时发生的遗传变化的影响.
- 关于KRAS突变亚型及其在拉丁美洲人口中的临床影响的数据有限.
研究的目的:
- 在肺腺癌中描述KRAS突变的分子异质性.
- 研究拉丁美洲队列中KRAS亚型与临床结果之间的关联.
- 为了确定特定的KRAS变化的潜在预后影响.
主要方法:
- 在墨西哥国家癌症研究所 (INCan) 进行了一项回顾性队列研究.
- 包括患有晚期肺腺癌和KRAS突变的患者,通过下一代测序证实.
- 2014年6月至2023年3月期间收集了临床和病理数据.
主要成果:
- 在346名患者中,KRAS突变在15.6%的患者中被发现;分析了50人.
- 克拉斯G12D和克拉斯G12C是最常见的亚型 (分别为32%).
- KRASG12D与女性性别相关,从未吸烟,并与EGFR和CDKN2A共同发生. 患有KRASG12D的患者显著改善了目标反应率 (ORR),无进展生存期 (PFS) 和整体生存期 (OS).
结论:
- 这项研究是第一个全面描述拉丁美洲KRAS突变非小细胞肺癌 (NSCLC) 的研究.
- 基因突变的NSCLC具有分子多样性,不同的亚型影响预后.
- 需要进行更大规模的,多中心的拉丁美洲研究来验证这些发现.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.4K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
